Serina Therapeutics SER
NYSE SER
$1.96 -0.03 (-1.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Return on Sales [ROS] (2018 - 2026)

Updated

Serina Therapeutics (SER) recorded Return on Sales [ROS] of -19190.77% in Q2 2026, down 14910.00 percentage points from -4280.77% a year earlier.

Analysis

Serina Therapeutics (SER) Return on Sales [ROS] (2018 - 2026) Analysis & Trends

For FY2025, Serina Therapeutics reported Return on Sales [ROS] of -18478.46%, up 11964.40 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -15680.68 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -30442.86% in FY2024 (-30343.62 pp), -99.24% in FY2023 (+20415.47 pp), -20514.71% in FY2022 (-15005.68 pp) and -5509.03% in FY2021 (-2711.24 pp).
  • Quarterly Return on Sales [ROS] has ranged from -46420.00% in Q1 2024 to 7.81% in Q4 2023 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last seven quarters, with an average year-over-year change of -5590.85 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 37833.33 percentage points in Q1 2023, against a drop of 43213.33 percentage points in Q1 2024 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 28.21%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 37.86%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 32.97%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 20.57%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -133.21%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 28.37%
10 Serina Therapeutics 32.61 Mn -8.13 Mn - -19,190.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19,190.77%
Dec 31, 2025 -18,478.46%
Sep 30, 2025 -20,141.38%
Jun 30, 2025 -4,280.77%
Mar 31, 2025 -40,362.75%
Dec 31, 2024 -30,442.86%
Sep 30, 2024 -37,942.86%
Jun 30, 2024 -7,580.39%
Mar 31, 2024 -46,420.00%
Dec 31, 2023 7.81%
Sep 30, 2023 -5,044.83%
Jun 30, 2023 -13,500.00%
Mar 31, 2023 -3,206.67%
Dec 31, 2022 -22,275.00%
Sep 30, 2022 -17,222.22%
Jun 30, 2022 -13,258.33%
Mar 31, 2022 -41,040.00%
Dec 31, 2021 -6,914.81%
Sep 30, 2021 -6,975.00%
Jun 30, 2021 -5,959.46%
API Access

Serina Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SER&period=max&api_key=YOUR_API_KEY